Chemexpress(SH:688131) Zheng Quan Zhi Xing·2025-05-28 11:03Summary of Key Points Core Viewpoint Shanghai Haoyuan Pharmaceutical Co., Ltd. has announced the issuance of convertible bonds, "Haoyuan Convertible Bonds," with a total amount of 82,235,000 RMB, which will be listed on the Shanghai Stock Exchange starting December 19, 2024. The bonds have a six-year term and specific terms for conversion into shares. Group 1: Issuance Details - The company will issue 8,223,500 convertible bonds, each with a face value of 100 RMB, totaling 82,235,000 RMB [1][3] - The bonds will be listed for trading on the Shanghai Stock Exchange under the code "118051" and the name "Haoyuan Convertible Bonds" starting December 19, 2024 [1] - The bond's term is six years, from November 28, 2024, to November 27, 2030 [1] Group 2: Conversion Terms - The coupon rates for the bonds are set to increase over the years, starting at 0.20% in the first year and reaching 2.00% in the sixth year [1] - The conversion period for the bonds will be from June 4, 2025, to November 27, 2030, with a current conversion price of 40.58 RMB per share [2][4] Group 3: Conversion Process - Holders can apply for conversion during the specified period on trading days, with the conversion process managed by the China Securities Depository and Clearing Corporation [2] - Newly converted shares will be listed for trading the day after the conversion application is approved [4] Group 4: Price Adjustment Mechanism - The initial conversion price was set at 40.73 RMB per share but has been adjusted to 40.58 RMB due to the company's stock incentive plan [5][6] - The conversion price may be adjusted based on various corporate actions, including stock dividends and capital increases [6][7] Group 5: Redemption and Sale Rights - The company has the right to redeem the bonds at 113% of the face value within five trading days after maturity if they remain unconverted [10] - Holders can sell back their bonds to the company if the stock price falls below 70% of the conversion price during the last two interest years [10][11] Group 6: Additional Information - Investors seeking more details can refer to the company's prospectus published on November 26, 2024, on the Shanghai Stock Exchange website [12]